Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antisense oligonucleotide therapy forKCNT1encephalopathy
Lisseth Estefania Burbano, Melody Li, Nikola Jancovski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 10

Showing 10 citing articles:

Impact of predictive, preventive and precision medicine strategies in epilepsy
Rima Nabbout, Mathieu Kuchenbuch
Nature Reviews Neurology (2020) Vol. 16, Iss. 12, pp. 674-688
Closed Access | Times Cited: 77
Genetic therapeutic advancements for Dravet Syndrome
Ellie Chilcott, Juan Antinao Díaz, Cori Bertram, et al.
Epilepsy & Behavior (2022) Vol. 132, pp. 108741-108741
Open Access | Times Cited: 36
Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention
Valentin K. Gribkoff, Raymond J. Winquist
Biochemical Pharmacology (2023) Vol. 208, pp. 115413-115413
Closed Access | Times Cited: 20
Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series
Andrew M. Griffin, Kristopher M. Kahlig, Robert J. Hatch, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 4, pp. 593-602
Open Access | Times Cited: 41
A Review of Targeted Therapies for Monogenic Epilepsy Syndromes
Vincent Zimmern, Berge A. Minassian, Christian Korff
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 27
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
Gemma L. Carvill, Tyler Matheny, Jay R. Hesselberth, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 1500-1514
Open Access | Times Cited: 27
Developmental and epileptic encephalopathies – therapeutic consequences of genetic testing
Steffen Syrbe
Medizinische Genetik (2022) Vol. 34, Iss. 3, pp. 215-224
Open Access | Times Cited: 9
Präzisionsmedizin für genetische Epilepsien – am Anfang des Weges?
Steffen Syrbe
Zeitschrift für Epileptologie (2021) Vol. 34, Iss. 2, pp. 161-167
Closed Access | Times Cited: 9
Rational Small Molecule Treatment for Genetic Epilepsies
Ethan M. Goldberg
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 1490-1499
Open Access | Times Cited: 8
Intolerance to quinidine in a n-of-1 trial for KCNT1 associated epilepsy of infancy with migrating focal seizures
Elaine Hughes, Stephanie Oates, Deb K. Pal
Seizure (2022) Vol. 103, pp. 46-50
Open Access | Times Cited: 3
Page 1

Scroll to top